Luke Miller

1.2k total citations · 1 hit paper
8 papers, 963 citations indexed

About

Luke Miller is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Luke Miller has authored 8 papers receiving a total of 963 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Oncology, 4 papers in Molecular Biology and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Luke Miller's work include Sarcoma Diagnosis and Treatment (3 papers), Vascular Tumors and Angiosarcomas (3 papers) and Cancer, Hypoxia, and Metabolism (2 papers). Luke Miller is often cited by papers focused on Sarcoma Diagnosis and Treatment (3 papers), Vascular Tumors and Angiosarcomas (3 papers) and Cancer, Hypoxia, and Metabolism (2 papers). Luke Miller collaborates with scholars based in United States, Finland and Canada. Luke Miller's co-authors include Abhishek Jha, Qi Wang, R. Brooks Robey, Prashanth T. Bhaskar, Krushna C. Patra, Eric L. Allen, Gromoslaw A. Smolen, William J. Muller, Nissim Hay and Navdeep S. Chandel and has published in prestigious journals such as Nucleic Acids Research, Cancer Cell and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

Luke Miller

7 papers receiving 952 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Hexokinase 2 Is Required for Tumor Initiation and Maintenance and Its Systemic Deletion Is Therapeutic in Mouse Models of Cancer

2013 677 citations Krushna C. Patra, Qi Wang et al. Cancer Cell profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Luke Miller United States	6	699	500	261	114	93	8	963
Burcu Yücel Türkiye	9	725 1.0×	554 1.1×	170 0.7×	171 1.5×	133 1.4×	21	1.1k
Jianjun Li China	18	684 1.0×	671 1.3×	224 0.9×	113 1.0×	88 0.9×	30	1.1k
Yun-Xin Lu China	13	806 1.2×	725 1.4×	262 1.0×	165 1.4×	66 0.7×	14	1.2k
Kate Huang China	19	550 0.8×	365 0.7×	142 0.5×	121 1.1×	103 1.1×	42	900
Hyun Min Jeon South Korea	13	657 0.9×	445 0.9×	355 1.4×	134 1.2×	50 0.5×	18	1.1k
Changzhi Huang China	21	1.0k 1.4×	697 1.4×	239 0.9×	119 1.0×	68 0.7×	56	1.3k
Xiaoting Jia China	19	941 1.3×	585 1.2×	227 0.9×	87 0.8×	63 0.7×	31	1.2k
Venugopal Gunda United States	16	642 0.9×	572 1.1×	282 1.1×	76 0.7×	82 0.9×	33	1.1k
Vijesh Kumar Yadav Taiwan	18	502 0.7×	310 0.6×	173 0.7×	147 1.3×	62 0.7×	41	814

Countries citing papers authored by Luke Miller

Since Specialization

Citations

This map shows the geographic impact of Luke Miller's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Luke Miller with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Luke Miller more than expected).

Fields of papers citing papers by Luke Miller

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Luke Miller. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Luke Miller. The network helps show where Luke Miller may publish in the future.

Co-authorship network of co-authors of Luke Miller

This figure shows the co-authorship network connecting the top 25 collaborators of Luke Miller. A scholar is included among the top collaborators of Luke Miller based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Luke Miller. Luke Miller is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

1.

Chowdhary, Mudit, Neilayan Sen, Elizabeth B. Jeans, et al.. (2018). Neoadjuvant Interdigitated Chemoradiotherapy Using Mesna, Doxorubicin, and Ifosfamide for Large, High-grade, Soft Tissue Sarcomas of the Extremity. American Journal of Clinical Oncology. 42(1). 1–5. 9 indexed citations

2.

Scott, Victoria, J. Wetter, Torben R. Neelands, et al.. (2016). 534 Defining a mechanistic link between TRPV3 activity and psoriasis through IL-1α and EGFR signaling pathways. Journal of Investigative Dermatology. 136(5). S94–S94. 5 indexed citations

3.

Wang, Xiao-Qi, et al.. (2016). Ganglioside GM3 Mediates Glucose-Induced Suppression of IGF-1 Receptor–Rac1 Activation to Inhibit Keratinocyte Motility. Journal of Investigative Dermatology. 137(2). 440–448. 28 indexed citations

4.

Sen, Neilayan, Marta Batus, Elizabeth B. Jeans, et al.. (2016). Improved Outcomes in Patients With Large, High-Grade Extremity Soft Tissue Sarcoma Treated With Mesna-Ifosfamide Doxorubicin (MAI) Neoadjuvant Chemotherapy and Interdigitated Radiation Therapy Followed by Resection and 3 More Cycles of MAI. International Journal of Radiation Oncology*Biology*Physics. 96(2). S24–S24.

5.

Patra, Krushna C., Qi Wang, Prashanth T. Bhaskar, et al.. (2013). Hexokinase 2 Is Required for Tumor Initiation and Maintenance and Its Systemic Deletion Is Therapeutic in Mouse Models of Cancer. Cancer Cell. 24(3). 399–399. 29 indexed citations

6.

Patra, Krushna C., Qi Wang, Prashanth T. Bhaskar, et al.. (2013). Hexokinase 2 Is Required for Tumor Initiation and Maintenance and Its Systemic Deletion Is Therapeutic in Mouse Models of Cancer. Cancer Cell. 24(2). 213–228. 677 indexed citations breakdown →

7.

Budke, Brian, Hillary L. Logan, Jay H. Kalin, et al.. (2012). RI-1: a chemical inhibitor of RAD51 that disrupts homologous recombination in human cells. Nucleic Acids Research. 40(15). 7347–7357. 143 indexed citations

8.

MacDermed, Dhara, Luke Miller, Terrance D. Peabody, et al.. (2009). Primary Tumor Necrosis Predicts Distant Control in Locally Advanced Soft-Tissue Sarcomas After Preoperative Concurrent Chemoradiotherapy. International Journal of Radiation Oncology*Biology*Physics. 76(4). 1147–1153. 72 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact